
Forever Labs
70% Stem Cell Banking / Storage ยท 20% Bone-Marrow-Derived Therapy ยท 10% Adipose-Derived Stem Cell Therapy
Starting from
$3,000

A Texas hormone pellet company that trains independent clinics, with one patient-facing training clinic of its own in Irving

Biote trains other people's clinics to do hormone pellet therapy. It is not a chain. About 9,200 certified practitioners work out of roughly 5,300 independently owned practices, and Biote's own annual report compares the arrangement to a franchise: the company supplies the two-day certification course, the dosing software, access to compounded pellets and a supplement line, and the individual clinic bills the patient. If you book with a Biote provider in your city, you are booking with a separate business that pays Biote for training and supply. The one exception is the Irving headquarters. The building on West Walnut Hill Lane holds the corporate offices, the call center and the National Training Center, and it also holds a working patient clinic operating as Resurge under Kris Wusterhausen, DO. Trainee clinicians perform supervised insertions there on real patients, which is how the certification course ends. The therapy is bioidentical estradiol or testosterone pressed into a pellet and placed under the skin of the upper buttocks during a short office visit. Dosing comes out of comprehensive lab work and a symptom questionnaire run through Biote's clinical decision software. Pellets dissolve over three to six months, so most patients return two to four times a year, and Biote's own FAQ warns it can take two insertions before the effect settles. The company counted around 400,000 active patients at the end of 2025 and says its providers have performed roughly 6 million procedures since 2012. About 85 percent of those procedures were for women. The pellets are compounded rather than FDA-approved, and they come from 503B outsourcing facilities including Biote's own subsidiary Asteria Health. That subsidiary recalled estradiol and testosterone pellets shipped between May 2025 and January 2026 over possible metal particulate, which the FDA classified as a Class II recall in February 2026. Compounded hormone pellets are also a contested category: a 2020 National Academies review found the evidence does not support them being as safe or effective as approved hormone products, and ACOG advises against prescribing them routinely where an approved formulation exists. Biote does not do stem cell, exosome or PRP work of any kind.
Board-Certified Physicians
Accreditations are records-based and do not imply endorsement of any treatment's safety or efficacy.
Starting from
On consultation
consult to quote
Biote publishes no patient prices, because it does not bill patients. Each certified clinic sets its own fee for an insertion and its own retail price on Biote supplements. Expect to get a number from the individual practice, not from Biote, and expect compounded pellets to sit outside insurance coverage.
Pricing is indicative and set by each clinic. Confirm the final cost directly before treatment.
Individual results vary and are not typical or guaranteed. Case studies and testimonials reflect one person's experience.
Komal Bajaj
Chief Medical Officer
MD, MS
An OB/GYN and clinical geneticist who still sees patients, appointed Biote's chief medical officer in June 2026. She was the first chief quality officer for NYC Health + Hospitals at Jacobi and North Central Bronx, a two-campus system covering about a million patients, and is a professor of obstetrics and gynecology at Albert Einstein College of Medicine. She has advised the Secretary of Health and Human Services through the AHRQ National Advisory Council and sat on The Joint Commission's chief physician council. MD from Northwestern, master's in health professions education from the MGH Institute.
Mickey Karram
Chair, Medical Advisory Board
MD
Director of urogynecology at The Christ Hospital in Cincinnati and a volunteer professor of OB/GYN at the University of Cincinnati. Board certified in obstetrics and gynecology and in female pelvic medicine and reconstructive surgery. Past president of the American Urogynecology Society, honorary editor-in-chief of the International Urogynecology Journal, and co-author of two standard texts on pelvic anatomy and reconstructive pelvic surgery.
Cory Rice
Chief Clinical Advisor
DO
Trained in internal medicine at Methodist Medical Center of Dallas, where he was chief resident, after a forensic science degree at Baylor and a DO from the Arizona College of Osteopathic Medicine. He founded Modern Medicine, a group of outpatient practices, holds certifications through the Institute for Functional Medicine and A4M, and says he has personally done more than 20,000 pellet procedures.
Bruce Dorr
Senior Medical Advisor
MD
OB/GYN subspecialised in female pelvic medicine and reconstructive surgery. Medical school at Wayne State, residency at the University of Colorado, where he later ran the urogynecology division and the urodynamics lab as an assistant professor. He leads the OB/GYN department and robotic surgery at Littleton Hospital in Colorado and has been with Biote since 2013.
Kris Wusterhausen
Physician, Biote Training Clinic
DO
The doctor patients actually see at the Irving site. Family medicine residency at the University of North Texas Health Science Center in Fort Worth, finishing as co-chief resident in 2001, and board certified through the American Osteopathic Board of Family Physicians. He ran the Campbell Clinic in Parker County from 2002 to 2019, trained with Cenegenics, opened the Resurge Clinic in 2008, and is certified in peptide therapy through the International Peptide Society.
Lisa Jukes
Medical Advisory Board
MD
Board-certified OB/GYN, UT Southwestern medical school in 1996 and residency there through 2000. She opened Modern Women's Health in Austin in 2004 and has been a Biote provider since the company started. She proctors for the Texas Institute of Robotic Surgery and speaks nationally for AbbVie.
Not yet verified
This clinic has not completed verification. Listings are still curated, but accreditation hasn't been confirmed.
Share a few details and Biote will reach out by email. Your information is never shown publicly.

70% Stem Cell Banking / Storage ยท 20% Bone-Marrow-Derived Therapy ยท 10% Adipose-Derived Stem Cell Therapy
Starting from
$3,000

30% IV / Systemic Cell Therapy ยท 25% Mesenchymal Stem Cell (MSC) Therapy ยท 15% Adipose-Derived Stem Cell Therapy
Starting from
$5,000

40% Regenerative Orthopedics ยท 25% Bone-Marrow-Derived Therapy ยท 20% Platelet-Rich Plasma (PRP)
Pricing on consultation